Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.

Antimicrobial Agents and Chemotherapy
Kerry L LaPlanteMichael J Rybak

Abstract

Controversy exists about the most effective treatment options for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) and about the ability of these strains to develop inducible resistance to clindamycin during therapy. Using both in vitro pharmacodynamic and murine thigh infection models, we evaluated and compared several antimicrobial compounds against CA-MRSA. Strains with inducible macrolide lincosamide-streptogramin type B (iMLS(B)) resistance and strains in which resistance was noninducible were evaluated. Two levels of inocula (10(5) and 10(7)) were evaluated for clindamycin activity in the in vivo model. In both models, the antimicrobial evaluation was performed in triplicate, and bacterial quantification occurred over 72 h, with drug doses that were designed to simulate the free drug area-under-the-concentration-time curve values (fAUCs) obtained from human samples. When the activity of clindamycin against the iMLS(B) strains was evaluated, constitutive resistance was noted at 24 h (MIC of >256), and failure was noted at an inoculum of > or =10(6) in the in vivo models. However, at a low inoculum (10(5)) in the murine thigh-infection model, clindamycin demonstrated modest activity, reducing the C...Continue Reading

References

Mar 7, 2000·Journal of Pharmaceutical and Biomedical Analysis·G W PengN Ozawa
May 17, 2001·Antimicrobial Agents and Chemotherapy·T GeeR Wise
May 17, 2001·Antimicrobial Agents and Chemotherapy·A L BarryS D Brown
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·R WiseG Marshall
Aug 17, 2002·The Pediatric Infectious Disease Journal·Arthur L FrankJohn P Quinn
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·D AndesW A Craig
Nov 7, 2002·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J G SlatterS Yamazaki
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Elizabeth A CoyleMichael J Rybak
Oct 15, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George K SiberryJames Dick
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Nasia SafdarW A Craig
May 18, 2004·Journal of Clinical Pharmacology·Barry Dvorchik, David Damphousse
Mar 16, 2005·Pharmacotherapy·Michael J Rybak, Kerry L LaPlante

❮ Previous
Next ❯

Citations

Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nimish PatelThomas P Lodise
Sep 18, 2009·The Journal of Antimicrobial Chemotherapy·Karen E BowkerAlasdair P MacGowan
Dec 23, 2009·The Journal of Antimicrobial Chemotherapy·Julia GloedeCharlotte Kloft
Nov 4, 2009·Antimicrobial Agents and Chemotherapy·Jeffrey FernandezKaren Bush
Apr 29, 2009·Antimicrobial Agents and Chemotherapy·Kyriaki KanellakopoulouEvangelos J Giamarellos-Bourboulis
Nov 16, 2011·Antimicrobial Agents and Chemotherapy·Anthony M NicasioGeorge L Drusano
Jan 1, 2009·The Libyan Journal of Medicine·A Salamat, A Byrne
Aug 25, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Marina GimenoLluís Luján
Feb 22, 2011·International Journal of Pharmaceutics·Luis Manuel PerezJesús Santamaría
Nov 30, 2013·TheScientificWorldJournal·Laurence Legout, Eric Senneville
Apr 19, 2017·The Journal of Bone and Joint Surgery. American Volume·John M ThompsonLloyd S Miller
Apr 8, 2018·Hospital Pediatrics·Sarah McBrideChristopher P Landrigan
Feb 10, 2016·Antimicrobial Agents and Chemotherapy·Rocío ÁlvarezJerónimo Pachón
Nov 14, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xiaoyu LiangHong Zhang
Jun 21, 2014·Clinical Pharmacology and Therapeutics·D GonzalezUNKNOWN Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.